Cita APA

López-Millán, B., Sánchez Martínez, D., Roca Ho, H., Gutiérrez-Agüera, F., Molina, O., Díaz de la Guardia, R., . . . Menéndez Bujan, P. (2019). NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.

Citación estilo Chicago

López-Millán, Belén|||0000-0002-9757-5454, et al. NG2 Antigen Is a Therapeutic Target for MLL-rearranged B-cell Acute Lymphoblastic Leukemia. 2019.

Cita MLA

López-Millán, Belén|||0000-0002-9757-5454, et al. NG2 Antigen Is a Therapeutic Target for MLL-rearranged B-cell Acute Lymphoblastic Leukemia. 2019.